VectivBio Holding AG

NASDAQ: VECT · Real-Time Price · USD
16.87
0.02 (0.12%)
At close: Jul 07, 2023, 9:59 PM

VectivBio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
27.34M n/a
Cost of Revenue
n/a n/a
Gross Profit
27.34M n/a
Operating Income
-80.52M -86.72M
Interest Income
676K n/a
Pretax Income
-93.63M -86.94M
Net Income
-93.73M -87.01M
Selling & General & Admin
33.91M 35.81M
Research & Development
73.95M 50.18M
Other Expenses
n/a 729K
Operating Expenses
107.86M 86.72M
Interest Expense
3.16M 36K
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
107.86M 86.72M
Income Tax Expense
107K 64K
Shares Outstanding (Basic)
44.13M 26.96M
Shares Outstanding (Diluted)
44.13M 26.96M
EPS (Basic)
-2.12 -3.23
EPS (Diluted)
-2.12 -3.23
EBITDA
-79.85M -86.41M
EBIT
-90.46M -86.87M
Depreciation & Amortization
676K 303K